These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression. Ramzan Z; Nassri AB; Huerta S Expert Rev Mol Diagn; 2014 Jun; 14(5):575-91. PubMed ID: 24831686 [TBL] [Abstract][Full Text] [Related]
48. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Helm J; Enkemann SA; Coppola D; Barthel JS; Kelley ST; Yeatman TJ Clin Cancer Res; 2005 Apr; 11(7):2478-85. PubMed ID: 15814623 [TBL] [Abstract][Full Text] [Related]
52. APC gene alterations in Barrett's metaplasia are implicated at an early stage in the carcinogenesis of esophageal adenocarcinoma. Fein M Am J Gastroenterol; 1997 Feb; 92(2):359-60. PubMed ID: 9040229 [No Abstract] [Full Text] [Related]
53. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Wilson KT; Fu S; Ramanujam KS; Meltzer SJ Cancer Res; 1998 Jul; 58(14):2929-34. PubMed ID: 9679948 [TBL] [Abstract][Full Text] [Related]
54. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Chao DL; Maley CC; Wu X; Farrow DC; Galipeau PC; Sanchez CA; Paulson TG; Rabinovitch PS; Reid BJ; Spitz MR; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1935-40. PubMed ID: 17035402 [TBL] [Abstract][Full Text] [Related]
55. Multistage carcinogenesis in Barrett's esophagus. Maley CC Cancer Lett; 2007 Jan; 245(1-2):22-32. PubMed ID: 16713672 [TBL] [Abstract][Full Text] [Related]
56. Barrett's esophagus. The significance of p53 in clinical practice. Ireland AP; Clark GW; DeMeester TR Ann Surg; 1997 Jan; 225(1):17-30. PubMed ID: 8998117 [TBL] [Abstract][Full Text] [Related]
57. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Maslyonkina KS; Konyukova AK; Alexeeva DY; Sinelnikov MY; Mikhaleva LM Cancer Med; 2022 Jan; 11(2):447-478. PubMed ID: 34870375 [TBL] [Abstract][Full Text] [Related]
58. [Intraepithelial neoplasia of Barrett's esophagus: prognosis of potential malignancy]. Werner M; Lassmann S Pathologe; 2011 Nov; 32 Suppl 2():197-201. PubMed ID: 22033682 [TBL] [Abstract][Full Text] [Related]
59. Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. Menke-Pluymers MB; van Drunen E; Vissers KJ; Mulder AH; Tilanus HW; Hagemeijer A Cancer Genet Cytogenet; 1996 Sep; 90(2):109-17. PubMed ID: 8830718 [TBL] [Abstract][Full Text] [Related]
60. Role of molecular biology in the follow-up of patients who have Barrett's esophagus. Casson AG Chest Surg Clin N Am; 2002 Feb; 12(1):93-111, ix-x. PubMed ID: 11901936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]